{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:38:17Z","timestamp":1792604297381,"version":"4.5.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Huntsman Cancer Institute Cancer Center Support","award":["P30 CA42014"],"award-info":[{"award-number":["P30 CA42014"]}]},{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Utah Clinical and Translational Science Institute"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR002538"],"award-info":[{"award-number":["UL1 TR002538"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Institute's SEER Program","award":["HHSN261201800016I"],"award-info":[{"award-number":["HHSN261201800016I"]}]},{"name":"US Center for Disease Control and Prevention's National Program of Cancer Registries","award":["NU58DP006320"],"award-info":[{"award-number":["NU58DP006320"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Interval breast cancer (IBC) is detected after a negative\/benign screening mammogram, but before the next expected screening mammogram. This study examined clinical characteristics and risk factors for 1\u201312 month (12\u2005m IBC) and 13\u201324 month (24\u2005m IBC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Utah medical records linked to cancer data were used to define a cohort of 149 769 women age 38\u201379 years with no history of breast cancer prior to a first-observed screening mammogram between 2005\u20132019, with at least one normal or benign (including probably benign) result. Index screening mammogram was defined as the last normal\/benign mammogram before a diagnostic mammogram or clinical encounter leading to a breast cancer diagnosis, but before the next expected screening. Cancers identified by the diagnostic mammogram or clinical encounter after the index mammogram defined an IBC. Clinical characteristics of 12\u2005m IBC were compared to 24\u2005m IBC using multivariable logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study population included 2122 women with IBC: 486 (22.9%) 12\u2005m IBC and 1636 (77.1%) 24\u2005m IBC. Compared to those \u226570 years, younger women were more likely to develop 12\u2005m vs 24\u2005m IBC (eg, age 38\u201349 years, OR = 2.34, 95%CI: 1.61\u20133.40, P &amp;lt; 0.01). Compared to 24\u2005m IBC, 12\u2005m IBC was associated with higher odds of axillary lymph node metastases (OR = 1.68, 95%CI: 1.29\u20132.19, P &amp;lt; 0.01); HER2+ cancer (OR = 2.10, 95%CI: 1.36\u20133.22, P &amp;lt; 0.01); triple negative cancer (OR = 2.08, 95%CI: 1.26\u20133.39, P &amp;lt; 0.01); and extremely dense breast tissue (OR = 2.05, 95%CI: 1.13\u20133.80, P &amp;lt; 0.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>12\u2005m IBC may be more aggressive than 24\u2005m IBC. Women under 70 years old may benefit from annual instead of biennial screening mammogram.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jbi\/wbag036","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:33:57Z","timestamp":1781004837000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics of Interval Breast Cancer Diagnosed Within 12 Months of a Normal Screening Mammogram Compared with Those Diagnosed Between 13\u201324 Months in Utah"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4411-1178","authenticated-orcid":false,"given":"Mei","family":"Wei","sequence":"first","affiliation":[{"name":"Huntsman Cancer Institute, University of Utah , Salt Lake City, UT ,","place":["USA"]},{"name":"Department of Internal Medicine, University of Utah , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pappas","sequence":"additional","affiliation":[{"name":"University of Utah , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Van Meter","sequence":"additional","affiliation":[{"name":"Intermountain Health , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe","family":"Freer","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, University of Utah , Salt Lake City, UT ,","place":["USA"]},{"name":"Department of Radiology, University of Utah , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saundra S","family":"Buys","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, University of Utah , Salt Lake City, UT ,","place":["USA"]},{"name":"Department of Internal Medicine, University of Utah , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Curtin","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, University of Utah , Salt Lake City, UT ,","place":["USA"]},{"name":"Department of Internal Medicine, University of Utah , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"2026102112413865800_wbag036-B1","author":"Wei"},{"issue":"3","key":"2026102112413865800_wbag036-B2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1470-2045(06)70617-9","article-title":"Radiological surveillance of interval breast cancers in screening programmes","volume":"7","author":"Houssami","year":"2006","journal-title":"Lancet Oncol"},{"key":"2026102112413865800_wbag036-B3","author":"National Comprehensive Cancer Network"},{"issue":"11S","key":"2026102112413865800_wbag036-B4","doi-asserted-by":"publisher","first-page":"S383","DOI":"10.1016\/j.jacr.2017.08.044","article-title":"ACR Appropriateness Criteria\u00ae Breast Cancer Screening","volume":"14","author":"Expert Panel on Breast Imaging","year":"2017","journal-title":"J Am Coll Radiol"},{"issue":"22","key":"2026102112413865800_wbag036-B5","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1001\/jama.2024.5534","article-title":"Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement","volume":"331","author":"US Preventive Services Task Force","year":"2024","journal-title":"JAMA"},{"issue":"6","key":"2026102112413865800_wbag036-B6","doi-asserted-by":"publisher","first-page":"e207227","DOI":"10.1001\/jamanetworkopen.2020.7227","article-title":"Comparison of Mortality Among Participants of Women\u2019s Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers","volume":"3","author":"Irvin","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026102112413865800_wbag036-B7","author":"University of Utah"},{"key":"2026102112413865800_wbag036-B8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.51964\/hlcs10916","article-title":"The Utah Population Database. The Legacy of Four Decades of Demographic Research","volume":"11","author":"Smith","year":"2021","journal-title":"Historical Life Course Studies"},{"key":"2026102112413865800_wbag036-B9","author":"D'Orsi"},{"key":"2026102112413865800_wbag036-B10","volume-title":"SEER Program Coding and Staging Manual 2025","author":"Adamo","year":"2025"},{"issue":"3","key":"2026102112413865800_wbag036-B11","doi-asserted-by":"publisher","first-page":"e00520","DOI":"10.34172\/jrhs.2021.57","article-title":"Factors for the Primary Prevention of Breast Cancer: A Meta-Analysis of Prospective Cohort Studies","volume":"21","author":"Poorolajal","year":"2021","journal-title":"J Res Health Sci"},{"issue":"2","key":"2026102112413865800_wbag036-B12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/ijc.32731","article-title":"Interval breast cancer risk associations with breast density, family history and breast tissue aging","volume":"147","author":"Nguyen","year":"2020","journal-title":"Int J Cancer"},{"issue":"9","key":"2026102112413865800_wbag036-B13","doi-asserted-by":"publisher","first-page":"e2018179","DOI":"10.1001\/jamanetworkopen.2020.18179","article-title":"Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers","volume":"3","author":"Niraula","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2026102112413865800_wbag036-B14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10549-025-07619-4","article-title":"Risk factors for interval breast cancer: insights from a decade of a mammography screening program","volume":"211","author":"Subelack","year":"2025","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"2026102112413865800_wbag036-B15","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/jnci\/djh269","article-title":"Factors contributing to mammography failure in women aged 40\u201349 years","volume":"96","author":"Buist","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2026102112413865800_wbag036-B16","doi-asserted-by":"publisher","first-page":"e2452821","DOI":"10.1001\/jamanetworkopen.2024.52821","article-title":"Cost-Effectiveness of Breast Cancer Screening Using Digital Mammography in Canada","volume":"8","author":"Wilkinson","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"13","key":"2026102112413865800_wbag036-B17","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/jnci\/92.13.1081","article-title":"Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers","volume":"92","author":"Mandelson","year":"2000","journal-title":"Natl Cancer Inst"},{"issue":"1","key":"2026102112413865800_wbag036-B18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/08465371211027958","article-title":"Breast Density and Risk of Interval Cancers: The Effect of Annual Versus Biennial Screening Mammography Policies in Canada","volume":"73","author":"Seely","year":"2022","journal-title":"Can Assoc Radiol J"},{"issue":"3","key":"2026102112413865800_wbag036-B19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.breast.2015.02.032","article-title":"A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer","volume":"24","author":"Meshkat","year":"2015","journal-title":"Breast"},{"issue":"12","key":"2026102112413865800_wbag036-B20","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/jnci\/djr138","article-title":"Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program","volume":"103","author":"Kirsh","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2026102112413865800_wbag036-B21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/jcp.53.2.140","article-title":"A study of interval breast cancer within the NHS breast screening programme","volume":"53","author":"Cowan","year":"2000","journal-title":"J Clin Pathol"},{"issue":"2","key":"2026102112413865800_wbag036-B22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00432-012-1304-1","article-title":"Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening","volume":"139","author":"Caldarella","year":"2013","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Journal of Breast Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbi\/advance-article-pdf\/doi\/10.1093\/jbi\/wbag036\/72258064\/wbag036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbi\/advance-article-pdf\/doi\/10.1093\/jbi\/wbag036\/72258064\/wbag036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:41:43Z","timestamp":1792600903000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbi\/advance-article\/doi\/10.1093\/jbi\/wbag036\/8965262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1093\/jbi\/wbag036","relation":{},"ISSN":["2631-6110","2631-6129"],"issn-type":[{"value":"2631-6110","type":"print"},{"value":"2631-6129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"article-number":"wbag036"}}